Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

R Zamora-Ros; C Sacerdote; F Ricceri; E Weiderpass; N Roswall; G Buckland; DE St-Jules; K Overvad; C Kyro; G Fagherazzi; M Kvaskoff; G Severi; J Chang-Claude; R Kaaks; U Noethlings; A Trichopoulou; A Naska; D Trichopoulos; D Palli; S Grioni; A Mattiello; R Tumino; IT Gram; D Engeset; JM Huerta; E Molina-Montes; M Argueelles; P Amiano; E Ardanaz; U Ericson; B Lindkvist; LM Nilsson; LA Kiemeney; M Ros; HB Bueno-de-Mesquita; PHM Peeters; K-T Khaw; NJ Wareham; V Knaze; I Romieu; A Scalbert; P Brennan; P Wark; P Vineis; E Riboli; CA Gonzalez

Journal article

Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

R Zamora-Ros, C Sacerdote, F Ricceri, E Weiderpass, N Roswall, G Buckland, DE St-Jules, K Overvad, C Kyro, G Fagherazzi, M Kvaskoff, G Severi, J Chang-Claude, R Kaaks, U Noethlings, A Trichopoulou, A Naska, D Trichopoulos, D Palli, S Grioni Show all

British Journal of Cancer | NATURE PUBLISHING GROUP | Published : 2014

DOI: 10.1038/bjc.2014.459

University of Melbourne Researchers

Gianluca Severi Author Melbourne School of Population and Global Health

Grants

Awarded by Health Research Fund (FIS) of the Spanish Ministry of Health

Awarded by regional government from, Murcia

Awarded by Spanish Ministry of Science and Innovation

Awarded by Cancer Research UK

Awarded by Medical Research Council

Awarded by National Institute for Health Research

Funding Acknowledgements

This work was supported by the European Commission: Public Health and Consumer Protection Directorate 1993 to 2004; Research Directorate-General 2005; Ligue contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health (RTICC DR06/0020/0091); the participating regional governments from Asturias, Andalucia, Murcia (no. 6236), Navarra and Vasco Country and the Catalan Institute of Oncology of Spain; Cancer Research UK and the Medical Research Council (United Kingdom); the Hellenic Health Foundation; Italian Association for Research on Cancer; Compagnia San Paolo, Italy; Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Dutch Prevention Funds; LK Research Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; Nordforsk-Centre of Excellence programme. Some authors are partners of ECNIS, a network of excellence of the 6FP of the EC. RZ-R is thankful for a postdoctoral programme Fondo de Investigacion Sanitaria (FIS; no. CD09/00133) from the Spanish Ministry of Science and Innovation.